Clinical trials
Phase 2 Anxiety Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
142 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 3 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 3 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 9 |
| 2025 | 19 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
| Recruiting | 23 |
| Terminated | 8 |
| Withdrawn | 7 |
| Unknown status | 7 |
| Active, not recruiting | 7 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 6 |
| National Institute of Mental Health (NIMH) | 6 |
| Brigham and Women's Hospital | 4 |
| Mclean Hospital | 4 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 4 |
| University of Florida | 3 |
| AstraZeneca | 2 |
| Canopy Growth Corporation | 2 |
| Dennis Charney | 2 |
| Duke University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 142 |
| Pain | 15 |
| Major Depressive Disorder | 12 |
| Stress Disorders, Post-Traumatic | 11 |
| Alcoholism | 9 |
| Generalized Anxiety Disorder | 8 |
| Autism Spectrum Disorder | 7 |
| Neoplasms | 7 |
| Mental Disorders | 6 |
| Mood Disorders | 6 |
Trials
Showing 1 to 25 of 142. Each trial links to its page on Pharma Observatory.
42 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.